ENDRA Life Sciences (NDRA) EPS (2017 - 2026)
ENDRA Life Sciences (NDRA) EPS from Jun 30, 2017 to Mar 31, 2026. The TTM ENDRA Life Sciences (NDRA) EPS is -$7.42. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
ENDRA Life Sciences (NDRA) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +18.82% |
| 3 Years TTM | -72.74% |
| 5 Years TTM | -60.23% |
| All Time TTM | -54.83% |
Annual EPS change of ENDRA Life Sciences (NDRA)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$1.06 | -82.33% |
| 2025 | -$5.98 | -72.13% |
| 2024 | -$21.44 | -85.03% |
| 2023 | -$143.22 | -49.80% |
| 2022 | -$285.29 | -38.87% |
| 2021 | -$466.66 | -56.75% |
| 2020 | -$1,078.99 | -63.89% |
| 2019 | -$2,988.12 | -22.71% |
| 2018 | -$3,866.03 | +86.98% |
| 2017 | -$2,067.58 | N/A |
Comparison ENDRA Life Sciences (NDRA) five years EPS CAGR with competitors
ENDRA Life Sciences (NDRA) five years EPS CAGR is -69.42%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| NOTV | Inotiv Inc | 62.28% | -189.71% |
| IQV | IQVIA Holdings Inc | 30.82% | -144.39% |
| MEDP | Medpace Holdings Inc | 29.42% | -142.38% |
| WAT | Waters Corp | 15.00% | -121.61% |
| TMO | Thermo Fisher Scientific Inc | 14.94% | -121.51% |
| IDXX | Idexx Laboratories Inc | 11.68% | -116.82% |
| A | Agilent Technologies Inc | 11.51% | -116.58% |
| MTD | Mettler-Toledo International Inc | 10.58% | -115.24% |
| DGX | Quest Diagnostics Inc | 8.13% | -111.71% |
| QGEN | Qiagen NV | 3.15% | -104.54% |
| GH | Guardant Health Inc | 1.05% | -101.51% |